FIELD: medicine; hematology. SUBSTANCE: patient's blood is subjected to intravascular irradiation with ultraviolet rays emitted in "C" region of ultraviolet spectrum, under pulsed conditions, at frequency going to scores of kHz. Ultraviolet irradiation prevents transformation of short- lived biological substances into stabler (but less active) products before they have time to react with non- irradiated blood components and with cells of blood vessels' endothemium. EFFECT: concentration of biologically active substance in blood can be increased. 2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INDUCING IMMUNE RESPONSE OF BODY | 1993 |
|
RU2118177C1 |
| METHOD FOR APPLYING THERAPEUTIC TREATMENT TO ORGANISM | 1996 |
|
RU2228531C2 |
| LIGHT TREATMENT DEVICE | 1994 |
|
RU2092200C1 |
| LIQUID MEDIA IRRADIATION DEVICE | 1994 |
|
RU2091092C1 |
| METHOD FOR TREATING MYOCARDIAL ISCHEMIA DISEASE | 1999 |
|
RU2157266C1 |
| METHOD FOR APPLYING LASER RADIATION TREATMENT | 2004 |
|
RU2282472C2 |
| METHOD FOR INDUCING OF IMMUNE RESPONSE OF MAMMALIAN ORGANISM-2 | 2004 |
|
RU2278704C2 |
| METHOD FOR INDIVIDUAL TREATMENT OF PATIENTS WITH BRONCHIAL ASTHMA | 2014 |
|
RU2564927C1 |
| METHOD OF OPTIMISATION TREATMENT OF BRONCHIAL ASTHMA | 2009 |
|
RU2403073C1 |
| METHOD FOR INDUCING BODY IMMUNE RESPONSE | 2001 |
|
RU2229890C2 |
